1. Home
  2. PEPG vs THRY Comparison

PEPG vs THRY Comparison

Compare PEPG & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PepGen Inc.

PEPG

PepGen Inc.

BUY

Current Price

$2.38

Market Cap

179.4M

Sector

Health Care

ML Signal

BUY

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

SELL

Current Price

$1.46

Market Cap

179.6M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
PEPG
THRY
Founded
2018
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
179.4M
179.6M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
PEPG
THRY
Price
$2.38
$1.46
Analyst Decision
Strong Buy
Hold
Analyst Count
8
4
Target Price
★ $10.19
$4.00
AVG Volume (30 Days)
★ 728.0K
639.3K
Earning Date
11-11-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
25.61
★ 100.50
EPS
N/A
★ N/A
Revenue
N/A
★ $785,015,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.31
$1.30
52 Week High
$7.80
$12.57

Technical Indicators

Market Signals
Indicator
PEPG
THRY
Relative Strength Index (RSI) 39.84 29.30
Support Level $1.60 N/A
Resistance Level $2.62 $4.25
Average True Range (ATR) 0.18 0.11
MACD -0.04 -0.01
Stochastic Oscillator 23.17 19.46

Price Performance

Historical Comparison
PEPG
THRY

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

Share on Social Networks: